Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
SEC Accession No. 0001104659-25-096168
Filing Date
2025-10-02
Accepted
2025-10-02 17:17:51
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 14D9/A tm2527813d1_sc14d9a.htm SC 14D9/A 17650
  Complete submission text file 0001104659-25-096168.txt   19529
Mailing Address YALELAAN 62 UTRECHT Netherlands
Business Address YALELAAN 62 UTRECHT Netherlands 31 6 3000 3035
LAVA Therapeutics NV (Filed by) CIK: 0001840748 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SC 14D9/A
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address YALELAAN 62 UTRECHT Netherlands
Business Address YALELAAN 62 UTRECHT Netherlands 31 6 3000 3035
LAVA Therapeutics NV (Subject) CIK: 0001840748 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SC 14D9/A | Act: 34 | File No.: 005-92425 | Film No.: 251370683
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)